In one paragraphArticle in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors at 4 institutions in 1 country.
Matthéo AlcarazCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France.ORCID 0000-0001-5308-9043 Chandramouli GhoshInstitut des Biomolécules Max Mousseron (IBMM), Université of Montpellier, CNRS, ENSCM, Montpellier, France.
John Jairo Aguilera-CorreaCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France.ORCID 0000-0002-4002-1944 Sébastien RicheterInstitut Charles Gerhardt Montpellier (ICGM), Université de Montpellier, CNRS, ENSCM, Montpellier, France.
Sébastien UlrichInstitut des Biomolécules Max Mousseron (IBMM), Université of Montpellier, CNRS, ENSCM, Montpellier, France.
Laurent KremerCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France.ORCID 0000-0002-6604-4458 École Nationale Supérieure de Chimie de Montpellier · FRUniversité de Montpellier · FRCentre National de la Recherche Scientifique · FRInserm · FR
Funding
Agence Nationale de la Recherche (ANR) ANR-16-IDEX-0006Agence Nationale de la Recherche (ANR) ILIome-20-CE44-0019Fondation pour la Recherche Médicale (FRM) EQU202103012588Ministère de l'Enseignement Supérieur, de la Recherche et de l'Innovation
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Anti-Bacterial AgentsBiofilmsMicrobial Sensitivity TestsMycobacterium abscessusMycobacterium Infections, NontuberculousPhotosensitizing AgentsPorphyrinsHumansLightPeptidesPhotochemotherapyAnti-Bacterial AgentsPeptidesPhotosensitizing AgentsPorphyrinsatomic force microscopyMycobacterium abscessusphotodynamic inactivationphotosensitizertherapeutic activity
Identifiers
PMID38619253
PMCPMC11064497
OpenAlexW4394808652
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390